SAN DIEGO, April 21 /PRNewswire/ -- Tensys Medical, developer of the T-line continuous, non-invasive blood pressure system, announced today the appointment of Christopher Jones as Chief Operating Officer. Mr. Jones joins Tensys from Nellcor, Inc., a division of Tyco International Ltd., where he has worked the last nine years, most recently as Vice President of Marketing. Nellcor, with over $700 million in world wide sales, is a leading manufacturer of anesthesia and critical care products. Prior to Nellcor Mr. Jones spent six years in sales and marketing management positions at BioGenex Laboratories. Chris is a graduate of Yale University with a Bachelor of Science degree in Molecular Biophysics and Biochemistry.
"Chris is an exceptional leader with a strong understanding of our key target markets," said Mike Martin, Chairman and CEO of Tensys(R) Medical. "He has a wealth of experience in driving new products from development through commercialization. As we move forward with the launch of the TL-150, I am pleased to be able to add someone with Chris' talent and abilities to the Tensys management team."
"I am excited about the opportunity to join Tensys," stated Chris Jones. "I have watched the company grow and develop their product line over the past several years. With the launch of the TL-150, I feel Tensys has solved one of the longstanding challenges associated with patient management in the operating room and is in a position to significantly impact patient safety."
Tensys Medical, Inc. is the leader in real-time blood pressure management. The Tensys T-Line, the company's lead product, was cleared by the FDA in November 2002 for non-invasive, continuous real-time blood pressure monitoring.
The Tensys T-Line measures a patient's blood pressure at the radial artery. It offers anesthesiologists better, more effective control over patient safety during surgery by allowing them to quickly monitor and manage blood pressure variations. The T-Line, via its continuous, real-time data, is far more effective than the traditional cuff method and has clinically equivalent accuracy to that of the arterial line (A-line). The device is based on Tensymetry, the company's proprietary and patented technology for non-invasively extracting the continuous, beat-to-beat pressure waveform from the radial artery without the use of any external calibration device. The science of Tensymetry is the result of over eight years of research and development.
Tensys Medical is based in San Diego, California and was founded in November 1995. For more information, please visit the company's Web site at http://www.tensysmedical.com/
CONTACT: Patti Duffy, Manager Customer Service of Tensys Medical,+1-888-722-7800, ext. 1, Support@tensysmedical.com